Kestra Medical Technologies (KMTS) Shares Outstanding (Weighted Average) (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $52.8 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $52.8 million, up 165.74% year-over-year; the trailing twelve-month figure through Jan 2026 was $52.8 million (up 165.74% YoY), and the FY2025 annual result was $24.6 million, up 23.63% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $52.8 million in Q1 2026 per KMTS's latest filing, from $51.3 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $52.8 million in Q1 2026 and troughed at $19.9 million in Q1 2024.
• A 3-year average of $31.1 million and a median of $19.9 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) changed 0.0% in 2025, then jumped 165.74% in 2026.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $19.9 million in 2024, then jumped by 158.18% to $51.3 million in 2025, then climbed by 2.93% to $52.8 million in 2026.
• Business Quant data shows KMTS's Shares Outstanding (Weighted Average) at $52.8 million in Q1 2026, $51.3 million in Q4 2025, and $51.3 million in Q3 2025.